Invivo

TriMed Staff | | Health Imaging | Screening
Invivo (Booth 3422) is introducing Luminescence, an FDA-cleared breast MRI coil system, specifically designed for sites utilizing 8, 16 and 32 channel MRI systems. The system is an ergonomic modular design with patient positioning accessories, available with both interventional coil and an optional 16-channel diagnostic coil. Invivo’s 16-channel Luminescence breast system delivers high signal-to-noise ratio, isotropic sub-millimeter voxel images, image uniformity and parallel imaging performance. The Luminescence 16 channel technology also optimizes the acquisition of imaging techniques, such as spectroscopy and diffusion.

TriMed Staff

Related Content

Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise

Around the web

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.